Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: A prospective cohort study

This study aimed to explore the correlation of circulating microRNA (miRNA) expression profile with clinical response to tumor necrosis factor (TNF) inhibitor in treating rheumatoid arthritis (RA) patients.

[1]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[2]  B. Zhao,et al.  MiR‐377 Regulates Inflammation and Angiogenesis in Rats After Cerebral Ischemic Injury , 2018, Journal of cellular biochemistry.

[3]  Lingling Zhu,et al.  MiR‐let‐7a regulates anti‐citrullinated protein antibody‐induced macrophage activation and correlates with the development of experimental rheumatoid arthritis , 2017, International immunopharmacology.

[4]  Xitao Wang,et al.  CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2 , 2017, Cellular Physiology and Biochemistry.

[5]  James T. Elder,et al.  miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. , 2017, The Journal of investigative dermatology.

[6]  Wei Zhao,et al.  Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  G. Schett,et al.  Pathogenetic insights from the treatment of rheumatoid arthritis , 2017, The Lancet.

[8]  G. Burmester,et al.  Novel treatment strategies in rheumatoid arthritis , 2017, The Lancet.

[9]  H. Yao,et al.  Relationship of miRNA-146a to primary Sjögren’s syndrome and to systemic lupus erythematosus: a meta-analysis , 2017, Rheumatology International.

[10]  Hui Jiang,et al.  Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritis. , 2017, Molecular bioSystems.

[11]  M. Cooper,et al.  Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis , 2017, Diabetes.

[12]  Ying Chen,et al.  The role of circulating miR-146a in patients with rheumatoid arthritis treated by Tripterygium wilfordii Hook F , 2017, Medicine.

[13]  M. Dougados,et al.  Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis , 2017, Annals of the rheumatic diseases.

[14]  Yan Jin,et al.  Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  K. Bogunia-Kubik,et al.  Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis , 2016, Archivum Immunologiae et Therapiae Experimentalis.

[16]  Christina Backes,et al.  miEAA: microRNA enrichment analysis and annotation , 2016, Nucleic Acids Res..

[17]  S. Bracke,et al.  Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate-to-severe psoriasis , 2016, European Journal of Dermatology.

[18]  Ashish Ranjan Sharma,et al.  miRNA‐Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis , 2016, Medicinal research reviews.

[19]  Hong-Jie Zhang,et al.  miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. , 2016, World journal of gastroenterology.

[20]  Geeta Rai,et al.  Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus , 2016, Immunologic research.

[21]  M. Knip,et al.  MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. , 2015, Autoimmunity reviews.

[22]  Y. Konttinen,et al.  The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review , 2015, PloS one.

[23]  N. Barbarroja,et al.  Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα , 2015, Arthritis Research & Therapy.

[24]  P. Ridker,et al.  A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. , 2013, American journal of epidemiology.

[25]  Huangxian Ju,et al.  MicroRNA: function, detection, and bioanalysis. , 2013, Chemical reviews.

[26]  J. Yao,et al.  Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis , 2013, Inflammation Research.

[27]  A. Barton,et al.  Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort , 2012, Arthritis Research & Therapy.

[28]  Wu-xian Li,et al.  Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. , 2012, Translational research : the journal of laboratory and clinical medicine.

[29]  Yvonne Bordon.  Autoimmunity: MicroRNA-23b keeps TABs on tissue inflammation , 2012, Nature Reviews Immunology.

[30]  M. Ochi,et al.  The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. , 2011, Arthritis and rheumatism.

[31]  Juan Li,et al.  [Expression of miR-146a and miR-16 in peripheral blood mononuclear cells of patients with rheumatoid arthritis and their correlation to the disease activity]. , 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[32]  N. Adachi,et al.  MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients , 2010, BMC musculoskeletal disorders.

[33]  Joshua J. Forman,et al.  let-7 Overexpression Leads to an Increased Fraction of Cells in G2/M, Direct Down-regulation of Cdc34, and Stabilization of Wee1 Kinase in Primary Fibroblasts* , 2009, Journal of Biological Chemistry.

[34]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[35]  Kaleb M. Pauley,et al.  Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2008, Arthritis research & therapy.

[36]  R. Burt,et al.  Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. , 2008, JAMA.

[37]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[38]  Yvonne Bordon.  In the news , 1967, Nature reviews. Immunology.

[39]  C. Nielsen,et al.  Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis , 2016, Clinical Rheumatology.

[40]  M. Prevoo,et al.  Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. , 1996, Arthritis and rheumatism.